sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 28/06/2011
PIL Priadel 200mg & 400mg prolonged release tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/06/2011 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 12/01/2011 and displayed until 28/06/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 20/10/2010 and displayed until 12/01/2011
Reasons for adding or updating:
  • Individual presentations superseded by joint PIL
Updated on 23/07/2008 and displayed until 20/10/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 18/07/2007 and displayed until 23/07/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to how to administer the medicine
Updated on 22/10/2004 and displayed until 18/07/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to drug interactions
  • Change to side-effects
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
Updated on 18/10/2002 and displayed until 22/10/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   lithium carbonate